871 related articles for article (PubMed ID: 19056420)
1. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
[TBL] [Abstract][Full Text] [Related]
2. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
Xie HR; Hu LS; Li GY
Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid differentiated SH-SY5Y human neuroblastoma cells: an in vitro model to assess drug neurotoxicity.
Nicolini G; Miloso M; Zoia C; Di Silvestro A; Cavaletti G; Tredici G
Anticancer Res; 1998; 18(4A):2477-81. PubMed ID: 9703895
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins.
Tieu K; Zuo DM; Yu PH
J Neurosci Res; 1999 Nov; 58(3):426-35. PubMed ID: 10518116
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells.
Jaworska-Feil L; Jantas D; Leskiewicz M; Budziszewska B; Kubera M; Basta-Kaim A; Lipkowski AW; Lason W
Neuropeptides; 2010 Dec; 44(6):495-508. PubMed ID: 20869113
[TBL] [Abstract][Full Text] [Related]
6. Activation of Rac1 by phosphatidylinositol 3-kinase in vivo: role in activation of mitogen-activated protein kinase (MAPK) pathways and retinoic acid-induced neuronal differentiation of SH-SY5Y cells.
Pan J; Kao YL; Joshi S; Jeetendran S; Dipette D; Singh US
J Neurochem; 2005 May; 93(3):571-83. PubMed ID: 15836616
[TBL] [Abstract][Full Text] [Related]
7. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells.
Kim SN; Kim SG; Park SD; Cho-Chung YS; Hong SH
J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609
[TBL] [Abstract][Full Text] [Related]
8. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells.
Nakaso K; Ito S; Nakashima K
Neurosci Lett; 2008 Feb; 432(2):146-50. PubMed ID: 18201823
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells.
Mathiasen JR; McKenna BA; Saporito MS; Ghadge GD; Roos RP; Holskin BP; Wu ZL; Trusko SP; Connors TC; Maroney AC; Thomas BA; Thomas JC; Bozyczko-Coyne D
Brain Res; 2004 Apr; 1003(1-2):86-97. PubMed ID: 15019567
[TBL] [Abstract][Full Text] [Related]
10. RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.
Lopes FM; da Motta LL; De Bastiani MA; Pfaffenseller B; Aguiar BW; de Souza LF; Zanatta G; Vargas DM; Schönhofen P; Londero GF; de Medeiros LM; Freire VN; Dafre AL; Castro MA; Parsons RB; Klamt F
Neurotox Res; 2017 May; 31(4):545-559. PubMed ID: 28155214
[TBL] [Abstract][Full Text] [Related]
11. The Neuroprotective Role of Insulin Against MPP(+) -Induced Parkinson's Disease in Differentiated SH-SY5Y Cells.
Ramalingam M; Kim SJ
J Cell Biochem; 2016 Apr; 117(4):917-26. PubMed ID: 26364587
[TBL] [Abstract][Full Text] [Related]
12. Neuronal cell differentiation of human neuroblastoma cells by retinoic acid plus herbimycin A.
Preis PN; Saya H; Nádasdi L; Hochhaus G; Levin V; Sadée W
Cancer Res; 1988 Nov; 48(22):6530-4. PubMed ID: 2846152
[TBL] [Abstract][Full Text] [Related]
13. JNK pathway is required for retinoic acid-induced neurite outgrowth of human neuroblastoma, SH-SY5Y.
Yu YM; Han PL; Lee JK
Neuroreport; 2003 May; 14(7):941-5. PubMed ID: 12802179
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells.
Lin YC; Uang HW; Lin RJ; Chen IJ; Lo YC
J Pharmacol Exp Ther; 2007 Dec; 323(3):877-87. PubMed ID: 17855475
[TBL] [Abstract][Full Text] [Related]
15. The neuroprotective role of tissue inhibitor of metalloproteinase-2 in MPP+- or 6-OHDA-treated SK-N-BE(2)C and SH-SY5Y human neuroblastoma cells.
Kim SY; Woo MS; Park JS; Hyun JW; Kim YS; Kim HS
Neurosci Lett; 2010 Jan; 468(2):136-40. PubMed ID: 19883732
[TBL] [Abstract][Full Text] [Related]
16. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
[TBL] [Abstract][Full Text] [Related]
17. Involvement of extracellular signal-regulated kinases 1/2 and (phosphoinositide 3-kinase)/Akt signal pathways in acquired resistance against neurotoxin of 6-hydroxydopamine in SH-SY5Y cells following cell-cell interaction with astrocytes.
Jiang Z; Yu PH
Neuroscience; 2005; 133(2):405-11. PubMed ID: 15878643
[TBL] [Abstract][Full Text] [Related]
18. Differential antiapoptotic effect of erythropoietin on undifferentiated and retinoic acid-differentiated SH-SY5Y cells.
Wenker SD; Chamorro ME; Vota DM; Callero MA; Vittori DC; Nesse AB
J Cell Biochem; 2010 May; 110(1):151-61. PubMed ID: 20225234
[TBL] [Abstract][Full Text] [Related]
19. Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells.
Presgraves SP; Borwege S; Millan MJ; Joyce JN
Exp Neurol; 2004 Nov; 190(1):157-70. PubMed ID: 15473989
[TBL] [Abstract][Full Text] [Related]
20. Okadaic acid protects human neuroblastoma SH-SY5Y cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis.
Ahn KH; Kim YS; Kim SY; Huh Y; Park C; Jeong JW
Neurosci Lett; 2009 Jan; 449(2):93-7. PubMed ID: 19000740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
